Mike Hollan

The two organizations will produce educational materials about the medicine and its importance for people living with type 1 and 2 diabetes.

This is the latest AI tool from the company to provide insights from public sources.

As investors react to an ever-changing political climate, Ash Shehata from KPMG explains what factors they're paying attention to.

Ash Shehata from KPMG discusses how investors are feeling about the pharma and life sciences industry heading into 2025.

The EY executive discusses trends in this sector and what he expects to see in the coming year.

Jason Foster, CEO of Ori Biotech, discusses the difficulties preventing more widespread adoption of these advanced therapies.

The technology is part of a larger platform that provides a variety of AI-powered services.

The company revealed plans to increase the usage of AI in pharma at JP Morgan’s healthcare conference in San Francisco.

Moderna provided updates on key elements of its pipeline, including a next-generation COVID-19 vaccine, an RSV vaccine, a new seasonal flu, and a combination seasonal flu/COVID vaccine.

The association also named Jim Weiss as honorable mentor and Rebecca Vermeulen as its STAR recipient.

The company provided information about its upcoming oncology portfolio, along with developments from its MoDE platform.

The Swiss company is focused on developing treatments for respiratory conditions, such as asthma and COPD.

Company leadership urged members and employees to stay safe and follow evacuation orders.

Dan Monahan will serve in the role as the drug goes through Phase III trials.

‘Shape Shifting’ is a creator-led series that focuses on the scientific and cultural impact of GLP-1s.

The campaign will include patient stories, education resources, and is being held in partnership with the Glaucoma Research Foundation.

Mary Kosinski joined the firm as global managing director for the sector, along with other leadership additions.

Both companies have produced AI-powered technology that improves data collection and analysis.

Deloitte’s US life sciences sector leader discusses the trends he believes will have the most impact in 2025.

Pavone discusses how these methods can be used to combat a lack of diversity in clinical trials.

The campaign is focused on the drug’s ability to fight hunger cravings.

The partnership will allow CMI to use Anoki’s AI technology to provide targeted advertising.

GlobalData’s new findings show that the Zepbound may become the top WLM in the coming year.

Artificial Intelligence took the industry by storm this year, but how is actually being implemented?

GLP-1s continue to dominate the market, but can pharma keep up with the demand?

Point of care messaging and AI resulted in more targeted campaigns over the past year.

New technologies are creating more efficient ways for pharma companies to work directly with consumers.

Pharm Exec covered key players in the industry over the past year.

In the third part of this roundtable discussion, experts discuss the issues with data that AI must overcome.

Sermo’s survey also reveals some troubling aspects about the public’s relationship with these medications.